Evidence map›Paper›PMID 25056273›Full record

ArticleScientific reports2014

The K898E germline variant in the PP1-binding motif of BRCA1 causes defects in DNA Repair.

Bert Yu-Hung Chen, Cheng-Hsiang Huang, Ying-Hsi Lin, Ching-Chun Huang, Chu-Xia Deng, Lih-Ching Hsu

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Bert Yu-Hung ChenSchool of Pharmacy, College of Medicine, National Taiwan University, Taipei 10050, Taiwan, ROC.
Cheng-Hsiang HuangSchool of Pharmacy, College of Medicine, National Taiwan University, Taipei 10050, Taiwan, ROC.
Ying-Hsi LinSchool of Pharmacy, College of Medicine, National Taiwan University, Taipei 10050, Taiwan, ROC.
Ching-Chun HuangSchool of Pharmacy, College of Medicine, National Taiwan University, Taipei 10050, Taiwan, ROC.
Chu-Xia DengGenetics of Development and Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Lih-Ching HsuSchool of Pharmacy, College of Medicine, National Taiwan University, Taipei 10050, Taiwan, ROC.
National Taiwan University · TWNational Institutes of Health · US

Funding

Chemoprevention and therapeutic treatment of BRCA1 associated mammary tumorsZIADK056009 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI DENG, CHUXIA · 2009 to 2014
$4.0M
Roles of BRCA1 transcription target genes in tumorigenesis and agingZIADK056011 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI DENG, CHUXIA · 2009 to 2014
$3.9M
Regulation of BRCA1 Function by Protein Phosphatase 1R01CA111436 · NCI · NATIONAL TAIWAN UNIVERSITY · PI HSU, LIH-CHING · 2005 to 2009
$706k
NCI NIH HHS R01 CA111436NCI NIH HHS R01CA111436
6 · The paper itself

Abstract

BRCA1 is a phosphoprotein involved in many biological processes, including transcription, ubiquitination, checkpoint control, homologous recombination, and DNA repair. We have demonstrated that protein phosphatase 1α (PP1α) interacts with BRCA1 via a PP1-binding motif (898)KVTF(901), and can dephosphorylate multiple serine residues phosphorylated by checkpoint kinases. A K898E germline missense variant in the PP1-binding motif of BRCA1 has been found in an Ashkenazi patient and a non-Ashkenazi Argentinean patient with breast and ovarian cancer, but its clinical significance is still unknown. Here we report that the lysine residue in the PP1-binding motif of BRCA1 is highly conserved across many mammalian species. The K898E mutation interferes with the interaction between BRCA1 and PP1α. Moreover, while the expression of wild-type BRCA1 in Brca1-deficient cells improved cell survival after DNA damage induced by ionizing radiation (IR), expression of BRCA1 K898E proved unable to enhance cell survival. DNA damage repair mechanisms remained defective in these BRCA1 K898E-reconstituted cells, as revealed by the comet assay and IR-induced Rad51 foci formation assay. These results reflect the significance of the interaction between BRCA1 and PP1, and indicate that the K898E variant may render carriers susceptible to DNA damage and malignant transformation.

Indexed as

DNA RepairMutation, MissenseAmino Acid SequenceAnimalsBinding SitesBRCA1 ProteinCell Line, TumorChlorocebus aethiopsConserved SequenceCOS CellsGenetic Association StudiesGenetic Predisposition to DiseaseHereditary Breast and Ovarian Cancer SyndromeMiceMolecular Sequence DataProtein Structure, TertiaryBRCA1 ProteinBRCA1 protein, humanRAD51 protein, humanRad51 Recombinase

Identifiers

PMID25056273
PMCPMC4108927
OpenAlexW2007433868

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.